Home › Blast Crisis › Texas › Houston

Pag-aaral pangklinika para sa Blast Crisis sa Houston, TX

6 pag-aaral para sa Blast Crisis ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Houston (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

Nagre-recruitPhase 2

M D Anderson Cancer Center, Houston

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT02115295

Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers

Nagre-recruitPhase 2

M D Anderson Cancer Center, Houston

Edad 12 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT03589729

Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia

Nagre-recruitPhase 2

M D Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT03263572

Asciminib Roll-over Study

Nagre-recruitPhase 4

Uni Of TX MD Anderson Cancer Cntr, Houston

Edad 7 hanggang 100 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT04877522

Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

Nagre-recruitPhase 1

M D Anderson Cancer Center, Houston

Edad 1 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT03630991

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Nagre-recruitPhase 1

University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2025 · NCT04260022

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.